Clinical Trial Update: Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy and safety of the ezetimibe/rosuvastatin combination (EzetimiBe/Rosuvastatin) in patients with type 2 diabetes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertriglyceridemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Ezetimibe/Rosuvastatin (ezetimibe/rosuvastatin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Endocrine System Diseases, Nutritional and Metabolic Diseases | Phase 4 | Status: COMPLETED